500
Participants
Start Date
May 3, 2017
Primary Completion Date
February 1, 2021
Study Completion Date
December 31, 2024
Substance misuse screening
Diagnostic and Statistical manual of mental disorders, version 4 (DSM-IV)/MINI-international Neuropsychiatric interview (MINI interview) for Diagnostics of dependence, additional questions for DSM-V classification, severity of dependence scale (SDS)
EQ-5D
Health related Quality of life
Impulsivity screening
Barratts impulsivity test v. 11, Behavioural inhibition/behavioural activation test
Cognitive screening
Minimental state examination (MMSE), Hospital anxiety and depression scale (HADS), Trail-making test, clock drawing test
Functional tests
Timed up and go (TUG), Single leg balancing test (SLB)
Cognistat
Assessment of cognitive domains
Neuropsychological profiling
Controlled Oral Word Association Test, Categorical fluency tests, Wechsler Adult Intelligence Scale, Color-Word Interference Test (CWIT) from the Delis-Kaplan Executive Function test
Clinical interview
Interview for sociodemographics, utilisation of health care, economic varables, The De Jong Gierveld Loneliness Scale
Medication use
Detailed screen of used medications, interactions, side effects in electronic patient registry
Comorbidity
Charlson comorbidity index and Cumulated illness rating scale (CIRS) based on electronic patient registry
Akershus University Hospital, Lørenskog
King's College London
OTHER
University of Oslo
OTHER
University Hospital, Akershus
OTHER